Sarah FaircliffeSenior Legal Consultant at Bird & BirdSpeaker
Profile
Sarah is a Senior Legal Consultant for Bird & Bird. She specialises in European regulatory law concerning medicinal products, medical devices and related areas.
Sarah spent 10 years as a Legal Adviser with the European Medicines Agency (EMA); during this time, she covered many areas, including orphan drugs, paediatrics and generics of centrally authorised products, as well as advising the EMA's scientific committees on various legal issues. She played a key role in the project to ensure that the new EU member states joining in 2004 brought their pharma legislation and procedures into line with EU requirements. Working closely with the European Commission, she worked on litigious matters and the drafting and implementation of various pieces of legislation. Sarah also has experience of the workings of other key EU regulators including the European Food Safety Authority.
At Bird & Bird, Sarah uses her in-depth knowledge of the regulatory framework to assist a wide range of clients on all aspects of the regulation of products in the life sciences sector. This ranges from advising on the correct interpretation of legislation, guidelines and case law to helping to steer clients through procedures and negotiations relating to the marketing of their products, including representing them in discussions with regulatory bodies. Much of this work involves working closely with Bird & Bird colleagues in other offices to provide pan-European regulatory advice. Strategies and disputes concerning regulatory data protection and orphan exclusivity are a particular focus of her work, including related litigation in the European Courts.
Sarah is a regular speaker at conferences and workshops and contributes to a number of publications.
Agenda Sessions
Orphan Drug Designation, Regulatory Consequences and Future Developments
10:00View Session
